The CEO has been on a buying spree for months. The syringe business is not the sexiest but I believe there is some value in this stock. The company has $46MM in cash and equivalents and1.5MM debt. 

Unlock the rest of this article with a 14 day trial

Unlock with Email
Unlock with Google

Already have an account?
Login here